Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2015 August;106(4) > Minerva Medica 2015 August;106(4):221-31

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLES   

Minerva Medica 2015 August;106(4):221-31

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Association between alterations in global DNA methylation and predisposing factors in diabetes: a high pressure liquid chromatography based study

Maghbooli Z. 1, Hossein-Nezhad A. 2, 3, Larijani B. 1, Pasalar P. 1, Keshtkar A. A. 2

1 Endocrinology and Metabolism Research Center, Endocrinology and Metabolism, Clinical Sciences Institute, Tehran, University of Medical Sciences, Tehran, Iran; 2 Osteoporosis Research Center, Endocrinology and Metabolism, Clinical Sciences Institute, Tehran, University of Medical Sciences, Tehran, Iran; 3 Department of Medicine, Section of Endocrinology, Nutrition and Diabetes, Vitamin D, Skin and Bone Research Laboratory, Boston University Medical Center, Boston, MA, USA


PDF


AIM: The aim of this study was to investigate the relationship between inter-individual global DNA methylation and diabetes predisposing factors.
METHODS: The 5-methyl cytosine content was assessed by reverse phase high pressure liquid chromatography (RP-HPLC) of peripheral blood leukocytes obtained from 178 type 2 diabetes patients to determine individual global DNA methylation status.
RESULTS: There was a positive significant correlation between diabetes duration and DNA methylation levels (P=0.002) with increasing levels of DNA methylation associated with age (P=0.047). There was no significant correlation between DNA methylation levels and HbA1c (P=0.15). No significant differences were observed between patients with and without diabetes predisposing factors including: hypertension (P=0.772), dyslipidemia (P=0.617), insulin resistance (homeostatic model assessment index) (P=0.156) and obesity (P=0.609). As such, the duration of diabetes (>10 years) was the most important predictor of global DNA methylation levels in diabetic patients after adjusting for age and sex (P=0.023).
CONCLUSION: Our findings indicate that chronic hyperglycemic exposure plays an independent role in global DNA methylation levels in type 2 diabetes patients.

top of page